Relmada Therapeutics, Inc. (RLMD) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,084
Total Return
-79.16%
CAGR
-26.92%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +5.20% |
| Median | +0.83% |
| Best | +185.97% |
| Worst | -88.79% |
| % of Windows Positive | 50.9% |
1-Year (252 Trading Days)
| Average | +145.17% |
| Median | -42.07% |
| Best | +2827.14% |
| Worst | -96.19% |
| % of Windows Positive | 37.0% |
3-Year (756 Trading Days)
| Average | -46.71% |
| Median | -89.01% |
| Best | +232.43% |
| Worst | -99.14% |
| % of Windows Positive | 19.4% |
Risk Metrics
| Maximum Drawdown | -99.32% |
| Average Drawdown | -74.43% |
| Drawdown Duration | 920 Trading Days (Unrecovered) |
| Sortino Ratio | 0.65 |
| Calmar Ratio | -0.27 |
| CVaR (5%) | -14.22% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +31.06% (+89.92% ann.) | +$3105.59 | $0.00 | $0.00 | $0.00 |
| 2025 | +828.81% | +$82881.04 | $0.00 | $0.00 | $0.00 |
| 2024 | -87.44% | $8743.91 | $0.00 | $0.00 | $0.00 |
| 2023 | +18.62% | +$1862.40 | $0.00 | $0.00 | $0.00 |
| 2022 | -84.51% | $8450.95 | $0.00 | $0.00 | $0.00 |
| 2021 | -29.75% | $2974.74 | $0.00 | $0.00 | $0.00 |
| 2020 | -17.77% | $1776.92 | $0.00 | $0.00 | $0.00 |
| 2019 | +747.82% | +$74782.24 | $0.00 | $0.00 | $0.00 |
| 2018 | +53.33% | +$5333.40 | $0.00 | $0.00 | $0.00 |
| 2017 | -31.19% | $3119.30 | $0.00 | $0.00 | $0.00 |
| 2016 | -56.40% | $5639.99 | $0.00 | $0.00 | $0.00 |
| 2015 | -83.87% | $8387.09 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +3.33% (+6.37% ann.) | +$333.33 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 20, 2014 – February 19, 2020 | -23.12% | -4.53% | $2311.67 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -44.23% | -99.87% | $4422.88 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +3.98% | +6.48% | +$397.78 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -43.23% | -41.56% | $4322.80 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -67.75% | -69.93% | $6774.92 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -41.10% | -24.84% | $4109.60 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +81.37% | +41.77% | +$8137.43 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.